Table 2.
Examples of biomarkers involved in neurological disorders. Adapted after [84]
| Biomarker | Physiological implications | Pathological effect | Disorder |
|---|---|---|---|
| Amyloid beta | Lipid homeostasis, memory formation, regulation of synaptic activity, neural viability | Oxidative stress, synaptic dysfunction, inflammation, apoptosis, neurite damage | Alzheimer’s disease |
| Tau protein | Promotes microtubules polymerization, stability, and flexibility | Neuronal damage, pro-apoptotic | Alzheimer’s disease, Parkinson’s disease |
| Alpha-synuclein | Intervenes in the release of neurotransmitters, modulates DNA repair processes | Synaptic and mitochondrial dysfunctions, oxidative stress, dysregulation of calcium signaling, microtubule impairment | Parkinson’s disease |
| Chromogranin A | Vasoconstriction, regulation of glucose metabolism and storage, modulator of the neuroendocrine system | Oxidative stress, inflammation, neuronal damage | Amyotrophic lateral sclerosis |
| Micro-RNAs | Nervous system development and function | Microglial activation, increase of proinflammatory cytokine release, and neuron loss | Autist spectrum disorders |